Literature DB >> 723012

The effect of blood oxygen content and the no-reflow phenomenon on the subendocardial ultrastructural reversibility following anoxic arrest using hemodilution variables in the experimental model.

M Sunamori, R G Trout.   

Abstract

Hemodilution is an accepted modality for the conduct of cardiopulmonary bypass. The degree of hemodilution clinically employed has been in the range of 20 per cent of the initial hematocrit levels. This study was designed to evaluate the effects of hemoglobin levels and oxygen content on the reversibility of the damaged or altered ultrastructure of the endocardial layer of the ventricle and the possible role of the no-reflow phenomenon. Two series of mongrel dogs were subjected to cardiopulmonary bypass at normothermic levels and a standard period of ischemic arrest. One series was with hemoglobin levels between 5 and 10 grams (mean 7.25 grams) designated as moderate hemodilution (MH). The second series was of hemodilution with less than 5 grams of hemoglobin (mean 4.8 grams) designated as severe hemodilution (SH). The ultrastructural alteration gradient (UAG) between the epicardium and endocardium was studied with its relationship to reversibility of myocardial function and animal survival. The study demonstrated a definitive relationship between oxygen content and the reversibility of myocardial damage under normothermic conditions and anoxic arrest. The poor survival results in the SH group; two of 12 are attributed to the low oxygen availability possibly triggering the no-reflow phenomenon which prevents reversibility of the myocardial ultrastructural damage and ultimately the functional integrity of the ventricle.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 723012     DOI: 10.1007/bf02469444

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  20 in total

1.  Noncoronary collateral myocardial blood flow.

Authors:  J Brazier; C Hottenrott; G Buckberg
Journal:  Ann Thorac Surg       Date:  1975-04       Impact factor: 4.330

2.  CLINICAL EXPERIENCE WITH BUFFERED RINGER'S LACTATE SOLUTION FOR TOTAL PRIME OF THE DISC OXYGENATOR DURING CARDIOPULMONARY BYPASS.

Authors:  W E NEVILLE; A SPINAZZOLA; F BANUCHI; L P SCICCHITANO; H PEACOCK
Journal:  J Thorac Cardiovasc Surg       Date:  1964-07       Impact factor: 5.209

3.  CARDIOPULMONARY BYPASS WITH LARGE VOLUME NONBLOOD PERFUSATE. EXPERIMENTAL AND CLINICAL OBSERVATIONS.

Authors:  W E NEVILLE; L SCICCHITANO; H MABEN; F BANUCHI; H PEACOCK
Journal:  Circulation       Date:  1965-04       Impact factor: 29.690

4.  Homologous blood syndrome: I. Preliminary observations on its relationship to clinical cardiopulmonary bypass.

Authors:  H L GADBOYS; R SLONIM; R S LITWAK
Journal:  Ann Surg       Date:  1962-11       Impact factor: 12.969

5.  The circulatory effects of hematocrit variations in normovolemic and hypervolemic dogs.

Authors:  J F MURRAY; P GOLD; B L JOHNSON
Journal:  J Clin Invest       Date:  1963-07       Impact factor: 14.808

6.  Cardiac output in acute experimental methemoglobinemia.

Authors:  C W GOWDEY
Journal:  Can J Biochem Physiol       Date:  1960-12

7.  The adequacy of myocardial oxygen delivery in acute normovolemic anemia.

Authors:  J Brazier; N Cooper; J V Maloney; G Buckberg
Journal:  Surgery       Date:  1974-04       Impact factor: 3.982

8.  Subendocardial ischemia after cardiopulmonary bypass.

Authors:  G D Buckberg; B Towers; D E Paglia; D G Mulder; J V Maloney
Journal:  J Thorac Cardiovasc Surg       Date:  1972-11       Impact factor: 5.209

9.  Ultrastructural, enzyme histochemical and light microscopic investigation of the myocardium in cases undergoing open-heart surgery.

Authors:  V O Björk; G Hultquist
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1967

10.  Protective effect of betamethasone on the subendocardial ischemia after the cardiopulmonary bypass.

Authors:  M Sunamori
Journal:  J Cardiovasc Surg (Torino)       Date:  1978 May-Jun       Impact factor: 1.888

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.